These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15530132)

  • 1. Assessment of levothyroxine sodium bioavailability: recommendations for an improved methodology based on the pooled analysis of eight identically designed trials with 396 drug exposures.
    Walter-Sack I; Clanget C; Ding R; Goeggelmann C; Hinke V; Lang M; Pfeilschifter J; Tayrouz Y; Wegscheider K
    Clin Pharmacokinet; 2004; 43(14):1037-53. PubMed ID: 15530132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New levothyroxine formulation meeting 95-105% specification over the whole shelf-life: results from two pharmacokinetic trials.
    Gottwald-Hostalek U; Uhl W; Wolna P; Kahaly GJ
    Curr Med Res Opin; 2017 Feb; 33(2):169-174. PubMed ID: 27718637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bioequivalence study of levothyroxine tablets versus an oral levothyroxine solution in healthy volunteers.
    Yannovits N; Zintzaras E; Pouli A; Koukoulis G; Lyberi S; Savari E; Potamianos S; Triposkiadis F; Stefanidis I; Zartaloudis E; Benakis A
    Eur J Drug Metab Pharmacokinet; 2006; 31(2):73-8. PubMed ID: 16898074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levothyroxine soft capsules demonstrate bioequivalent pharmacokinetic exposure with the European reference tablets in healthy volunteers under fasting conditions.
    Al-Numani D; Scarsi C; Ducharme MP
    Int J Clin Pharmacol Ther; 2016 Feb; 54(2):135-43. PubMed ID: 26754305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of two L-thyroxine formulations after oral administration to healthy dogs.
    Simpson C; Devi JL; Whittem T
    Aust Vet J; 2013 Mar; 91(3):83-8. PubMed ID: 23438458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence study of levothyroxine tablets compared to reference tablets and an oral solution.
    Koytchev R; Lauschner R
    Arzneimittelforschung; 2004; 54(10):680-4. PubMed ID: 15553108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers.
    Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R
    Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of total thyroxine in dogs after administration of an oral solution of levothyroxine sodium.
    Le Traon G; Burgaud S; Horspool LJ
    J Vet Pharmacol Ther; 2008 Apr; 31(2):95-101. PubMed ID: 18307500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic equivalence of a levothyroxine sodium soft capsule manufactured using the new food and drug administration potency guidelines in healthy volunteers under fasting conditions.
    Colucci P; D'Angelo P; Mautone G; Scarsi C; Ducharme MP
    Ther Drug Monit; 2011 Jun; 33(3):355-61. PubMed ID: 21516059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers.
    Estevez-Carrizo FE; Parrillo S; Ercoli MC; Estevez-Parrillo FT
    Clin Ther; 2011 Jun; 33(6):738-45. PubMed ID: 21704238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence study of two different tablet formulations of donepezil using truncated areas under the curve. A single-center, single-dose, randomized, open-label, 2-way crossover study under fasting conditions.
    Almeida S; Filipe A; Neves R; Desjardins I; Shink E; Castillo A
    Arzneimittelforschung; 2010; 60(3):116-23. PubMed ID: 20422942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
    Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A
    Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of Levothyroxine Bioequivalence Evaluation: Analysis of An Attempted Study.
    Mayor GH; Orlando T; Kurtz NM
    Am J Ther; 1995 Jun; 2(6):417-432. PubMed ID: 11850687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
    Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG
    Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.